Antisense antiviral agent and method for treating ssRNA viral infection
US8785407B2 · kind B2 · utility
38Cited by
48References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2006 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Nov 28, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/675
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antisense antiviral compounds and methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds have morpholino subunits linked by uncharged phosphorodiamidate linkages interspersed with cationic phosphorodiamidate linkages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.